Skip to content

Rogers Corporation ROG Accrued Expenses

Accrued Expenses at other companies

Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$1.23M-25.6%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$8.62M+40.0%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$152M-38.2%
Chemours logo
ChemoursCC
$122M-0.8%
Entegris logo
EntegrisENTG
$79.5M+13.9%
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Cash & equivalents$195.8M+11.5%
Total debt$29.8M-10.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%
Free cash flow$1.1M-47.6%

Valuation

See full
Market cap$2.84B+53.1%
Enterprise value$2.67B+57.7%
P/S3.5×+1.2×

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Return on equity-4.9%-6.3pp
Debt / equity0.0×
Current ratio+0.1×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's accrued expenses?
Rogers Corporation (ROG) reported accrued expenses of $18M in Q1 2026.
How has Rogers Corporation's accrued expenses changed year-over-year?
Rogers Corporation's accrued expenses decreased by 11.3% year-over-year, from $20.3M to $18M.
What is the long-term trend for Rogers Corporation's accrued expenses?
Over 5 years (2020 to 2025), Rogers Corporation's accrued expenses has grown at a -1.2% compound annual growth rate (CAGR), from $21.64M to $20.4M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.